Carlsmed, Inc. (CARL) Stock Forecast & Price Target
Carlsmed, Inc. · NASDAQ
$15.25-0.35 (-2.24%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Carlsmed, Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $17.00 to $23.00, so the covering firms are broadly aligned. The average target of $19.25 sits 26% above the current $15.25. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.34 next quarter toward $-1.38 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Strong Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Carlsmed, Inc.
As of Sep, 4 of 4 firms rate CARL a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CARL EPS & revenue forecast
EPS · NEXT QUARTER
$-0.34
Range $-0.35 – $-0.33 · 2 analysts · +15% YoY
Next period, 2 analysts expect Carlsmed, Inc. to earn $-0.34 a share (range $-0.35 – $-0.33), versus $-0.29 a year earlier. Full-year consensus is $-1.41, growing to $-1.38 the year after.
REVENUE · NEXT QUARTER
$22.5M
Range $21.5M – $23.4M · 2 analysts · +48% YoY
Revenue is expected to reach $22.5M (range $21.5M – $23.4M), +48.2% year-over-year. Full-year consensus is $76.7M, rising to $108.1M next year.
Top analysts covering Carlsmed, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CARL.
#1
David Saxon
Needham · Rank #347
Buy
$17.00+11.5% to target
Overall win rate
32%
+ Follow
#2
Matt O'Brien
Piper Sandler · Rank #424
Buy
$18.00+18.0% to target
Overall win rate
25%
+ Follow
#3
Richard Newitter
Truist Securities
Buy
$20.00+31.1% to target
Coverage
—
+ Follow
#4
Ryan Zimmerman
BTIG
Buy
$23.00+50.8% to target
Coverage
—
+ Follow
#5
David Roman
Goldman Sachs
Buy
$16.00+4.9% to target
Coverage
—
+ Follow
CARL stock forecast FAQ
What is CARL's average 12-month price target?+
The 4 analysts with a live target average $19.25 for Carlsmed, Inc. over the next 12 months, ranging from a $23.00 high to a $17.00 low.
Is CARL stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CARL?+
The Street-high target is $23.00 (BTIG), and the Street-low is $17.00 (Needham). The average of all 4 active targets is $19.25.
How many Wall Street analysts cover CARL?+
4 analysts have an active rating on Carlsmed, Inc., and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering CARL?+
Among analysts who currently cover CARL, David Saxon of Needham has the strongest overall Quantellect track record (Rank #347). Their current call is Buy with a $17.00 target.
What is Carlsmed, Inc.'s projected EPS for next quarter?+
The consensus estimate is $-0.34 per share (range $-0.35 – $-0.33) across 2 analysts. Full-year EPS is projected at $-1.41, rising to $-1.38 the following year.
How much revenue is Carlsmed, Inc. expected to report next quarter?+
Consensus revenue is $22.5M (range $21.5M – $23.4M). Full-year revenue is projected at $76.7M, growing to $108.1M next year.
Have analysts been upgrading or downgrading CARL lately?+
As of Sep, 4 of 4 firms rate CARL a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CARL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
